Etrebelle PLA + HA Implant in Pakistan: Evidence and Buying Guide
The PLA + HA Soft Tissue Injectable Implant listing appears to describe Etrebelle, a lyophilized hybrid implant combining poly-D,L-lactic acid and non-cross-linked hyaluronic acid.
A regulator-hosted Etrebelle instruction document supports the hybrid composition, while a separate European regulator notice confirms that counterfeit Etrebelle devices have circulated; exact pack and lot verification are therefore essential.
Catalogue visual: PLA + HA Soft Tissue Injectable Implant from the NEES Medical product catalogue. Packaging appearance alone does not establish authenticity; verify the supplied batch, expiry, seals and traceability documents.
What it is
Etrebelle is described in an Argentine regulator-hosted instruction document as a biodegradable PLA and HA soft-tissue injectable implant. Hybrid products in this category combine an HA component associated with early tissue support and a PLA component intended to drive a slower tissue response. The NEES catalogue uses both this generic-style title and a separate PLA + HA Filler title, so buyers should verify whether they are duplicate pages, distinct strengths or distinct presentations before procurement.
Market position and alternatives
This product occupies the hybrid biostimulator category between immediately volumizing HA gels and slower-onset single-material collagen stimulators.
| Option | Primary positioning | Important distinction |
|---|---|---|
| Etrebelle PLA + HA implant | Hybrid early support plus gradual biostimulation | Lyophilized PLA and non-cross-linked HA; exact strength must match the label |
| Cross-linked HA filler | Immediate contour or volume correction | Different gel behavior and a different reversibility pathway |
| PLLA or PDLLA biostimulator | Gradual collagen-oriented correction | Less immediate support and product-specific preparation requirements |
| CaHA filler | Structural support with biostimulatory positioning | Different material, imaging behavior and adverse-event profile |
Potential advantages
- A hybrid formula may offer a different onset profile from a PLA-only product.
- Regulator-hosted instructions provide a stronger identity reference than anonymous marketplace listings.
- The product category may suit clinics that already maintain competency in both filler safety and collagen-stimulator follow-up.
- The hybrid composition creates a clear comparison point when counselling patients about immediate versus gradual change.
Limitations and buying considerations
- Public evidence for Etrebelle itself is limited, and evidence for other PLA or HA products cannot establish equivalent outcomes.
- Hybrid implants may involve delayed inflammatory reactions, palpable nodules or other complications that require product-specific expertise.
- The two similar NEES catalogue titles create a product-identity risk that should be corrected before ordering.
- A counterfeit-device safety notice means unusually cheap or poorly documented stock should be treated as a material safety concern.
Quality and authenticity checklist
- Confirm the Etrebelle trade name, manufacturer, labelled PLA and HA quantities and vial count against current instructions.
- Inspect security features, lot and expiry data and compare them with the regulator's counterfeit-device notice.
- Request documented import and storage history and reject loose vials or packaging with inconsistent typography or identifiers.
- Record the exact strength and lot in the patient's clinical record because the generic catalogue title is not sufficiently specific.
Price and availability in Pakistan
The current Etrebelle PLA + HA Soft Tissue Injectable Implant price in Pakistan is available by quotation from NEES Medical; no verified numeric PKR price is published. A valid quotation should state the exact product name, PLA/HA strength, vial count, batch and expiry so clinics can compare like for like.
Clinical safety: This injectable implant requires an appropriately licensed and product-trained practitioner; do not provide or follow self-injection, preparation or dosing instructions. Direct all patient-specific, prescribing, procedural and administration questions to an appropriately qualified, licensed healthcare professional.
Sources and further reading
- ANMAT — Etrebelle Instructions for Use and Label
- Polish URPL — Etrebelle Counterfeit Medical Device Safety Notice
- US FDA — Dermal Fillers (Soft Tissue Fillers)
View the PLA + HA Soft Tissue Injectable Implant catalogue page or request current pricing and availability.
Frequently Asked Questions
What is the Etrebelle PLA + HA implant price in Pakistan?
The current PKR price is quotation required because the live catalogue does not publish a verified numeric price.
Is this the same product as the PLA + HA Filler listing?
The two catalogue descriptions appear closely related, but the public entries do not prove whether they are duplicates or separate presentations. Confirm the trade name and labelled composition on the actual stock before purchase.
How can a clinic verify genuine Etrebelle?
Use the current manufacturer instructions and regulator safety notice to check trade name, packaging, lot, expiry and security details. NEES Medical was not found on a public manufacturer distributor list in the sources reviewed.
How quickly are results visible?
Hybrid products are positioned around an early HA-related effect and a slower PLA-related tissue response, but timing and magnitude vary. A licensed practitioner should provide product-specific expectations without guarantees.
How should the product be stored?
Use only the storage conditions printed in the current instructions for the supplied lot, and reject stock with an undocumented temperature history or compromised sterile packaging.
About NEES Medical
Latest Posts
